Two More Patents Issued
East Lansing, Michigan (November 14, 2012): Retia Medical, LLC, announced today that two of its patent applications have issued. These patents, US 8,282,569 and US 8,273,031, expand Retia’s broad coverage in the area of cardiovascular signal processing to enable accurate monitoring of critically ill patients using less invasive sensors.
Recent Press Releases:
- Retia Medical Expands Distribution of Argos® Cardiac Output Monitor to Western Europe with Medtronic
- Retia Medical Appoints Bruce Brandes to Strategic Advisory Board
- Retia Medical Presents First Public Results for Non-Invasive Cardiac Output Algorithm
- Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments